Case Reports

Multivisceral resection for growing teratoma syndrome: overcoming pessimism


 

Growing teratoma syndrome (GTS) is a rare condition seen in patients with germ-cell tumors (GCT) who present with enlarging masses during or after appropriate chemotherapy with normalized serum markers.1 Three defining criteria for GTS are: a persistently growing tumor mass or evolving new mass during or after chemotherapy, normalization of tumor markers, and presence of only mature teratoma in the resected specimen on the final histopathological examination.1 Growing teratomas lack the metastatic potential; however, their relentless local growth causes compression and infiltration of adjacent organs, which produces symptoms.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Recognizing granulosa cell ovarian tumors
MDedge Hematology and Oncology
In-person, telephone genetic counseling yield similar outcomes
MDedge Hematology and Oncology
FDA reports shortage of doxorubicin for injection, initiates importation
MDedge Hematology and Oncology
Oophorectomy cost-effective at 4% lifetime ovarian cancer risk
MDedge Hematology and Oncology
Including quality-of-life scores may aid decision making for patients with advanced ovarian cancer
MDedge Hematology and Oncology
Women with BRCA1 mutations at higher risk for endometrial cancers
MDedge Hematology and Oncology
Hereditary breast and ovarian cancer: risk assessment in minority women and provider knowledge gaps
MDedge Hematology and Oncology
No difference between chemo regimens for ovarian clear cell carcinoma
MDedge Hematology and Oncology
Incidence of HPV-associated cancers on the rise
MDedge Hematology and Oncology
Women with ovarian cancer wait over a month to start treatment
MDedge Hematology and Oncology